HOME Top Market Reports Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology (RT-PCR, INAAT), End User (Physician Office, ICUS) - Global Forecast to 2023

Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology (RT-PCR, INAAT), End User (Physician Office, ICUS) - Global Forecast to 2023

By: marketsandmarkets.com
Publishing Date: May 2018
Report Code: MD 6292

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global point of care molecular diagnostics market was valued at USD 632.5 Million in 2017 and is projected to reach USD 1,440.2 Million in 2023, at a CAGR of 14.7%. The scope of the study includes POC molecular diagnostics analyzers and assays that enable healthcare professionals in the detection of diseases through molecular technologies in point-of-care settings. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023.

Objectives of the Study

  • To define, describe, and segment the global Point of care molecular diagnostics market by product & service, technology, application, end user, and region
  • To provide detailed information about factors influencing market growth (drivers, restraints, and opportunities)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global POC molecular diagnostics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
  • To profile the key players in the market and comprehensively analyze their market positions and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches and approvals, expansions, and other developments in the POC molecular diagnostics market

Research Methodology

Both, the top-down and bottom-up approaches were used to validate the size of the global Point of care molecular diagnostics market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market presence was studied through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, presentations, websites, and press releases of top players, news articles, journals; and paid databases ,white papers, medical journals, certified publications, articles from recognized authors, directories, and databases such as World Health Organization (WHO), European Diagnostic Manufacturers Association (EDMA), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), In Vitro Diagnostics Associations and Journals, Annual Reports, SEC Filings, Company Websites, Investor Presentations. Primary research included interviews with key opinion leaders such as CEOs, vice presidents, directors, marketing executives, and related key executives from various companies. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

Point of Care Molecular Diagnostics Market

To know about the assumptions considered for the study, download the pdf brochure

The key players in the global Point of care molecular diagnostics market are, Roche Diagnostics (Switzerland), Biomerieux (France), Danaher (US), Abbott Laboratories (US), Quidel (US) and Meridian Bioscience (US).

Target Audience:

  • POC Molecular Diagnostics Manufacturers
  • Physicians
  • Research Institutes
  • Diagnostics Suppliers
  • Market Research and Consulting Firms
  • Regulatory Bodies
  • Venture Capitalists

Scope of the Report:

The research report categorizes the global Point of care molecular diagnostics market into the following segments and subsegments:

  • Point of Care Molecular Diagnostics Market, by Product & Service

    • Assays & Kits
    • Instruments/Analyzers
    • Services & Software
  • Point of Care Molecular Diagnostics Market, by Application

    • Respiratory diseases
    • STDs
    • HAIs
    • Oncology
    • Hepatitis
    • Other Applications
  • Point of Care Molecular Diagnostics Market, by Technology

    • RT-PCR
    • INAAT
    • Others Technologies
  • Point of Care Molecular Diagnostics Market, by End User

    • Physician Offices
    • Hospital Emergency Departments & Intensive Care Units
    • Research Institutes
    • Other End User
  • Point of Care Molecular Diagnostics Market, by Region

    • North America
      • US
      • Canada
    • Europe
    • Asia Pacific
    • Rest of the World (RoW)

Available customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of each company

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

Detailed analysis of POC molecular diagnostics market in European countries such as the UK, Germany, France, Italy, Spain, and others
Detailed analysis of POC molecular diagnostics market in Asia Pacific countries such as China, Japan, India, and others

Table of Contents

1 Introduction (Page No. - 11)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 14)
    2.1 Primary Data
           2.1.1 Key Data From Primary Sources
           2.1.2 Key Industry Insights
    2.2 Secondary Data
           2.2.1 Key Data From Secondary Sources
    2.3 Market Size Estimation
    2.4 Market Breakdown and Data Triangulation
           2.4.1 Assumptions for the Study

3 Executive Summary (Page No. - 22)

4 Premium Insights (Page No. - 25)
    4.1 POC Molecular Diagnostics Market Overview
    4.2 Geographic Analysis: APAC POC Molecular Diagnostics Market, By Technology and Product
    4.3 POC Molecular Diagnostics Market, By Application
    4.4 POC Molecular Diagnostics Market, By End User

5 Market Overview (Page No. - 28)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Worldwide Prevalence of Infectious Diseases
                    5.2.1.2 Rising Focus on Decentralized Diagnostics
                    5.2.1.3 Growing Demand for Clia-Waived Molecular POC Tests
           5.2.2 Restraints
                    5.2.2.1 Inadequate Reimbursements
                    5.2.2.2 Stringent and Time-Consuming Regulatory Policies Significantly Increase the Product Launch Cycle
           5.2.3 Opportunities
                    5.2.3.1 Growing R&D Activities in Molecular Diagnostic Testing
                    5.2.3.2 Increasing Penetration of POC Molecular Diagnostic Tests in China, India, and Brazil

6 Point-of-Care (POC) Molecular Diagnostics Market, By Application (Page No. - 33)
    6.1 Introduction
           6.1.1 Respiratory Diseases
           6.1.2 Sexually Transmitted Diseases
           6.1.3 Hospital-Acquired Infections
           6.1.4 Oncology
           6.1.5 Hepatitis
           6.1.6 Other Applications

7 Point-of-Care Molecular Diagnostics Market, By Technology (Page No. - 41)
    7.1 Introduction
    7.2 RT -PCR
    7.3 INAAT
    7.4 Other Technologies

8 Point-of-Care (POC) Molecular Diagnostics Market, By Product & Service (Page No. - 46)
    8.1 Introduction
    8.2 Assays & Kits
    8.3 Instruments/Analyzers
    8.4 Software & Services

9 Point-of-Care Molecular Diagnostics Market, By End User (Page No. - 51)
    9.1 Introduction
    9.2 Physician Offices
    9.3 Hospital Emergency Departments & Intensive Care Units
    9.4 Research Institutes
    9.5 Other End Users

10 Point-of-Care Molecular Diagnostics Market, By Region (Page No. - 57)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
     10.4 Asia Pacific
     10.5 RoW

11 Competitive Landscape (Page No. - 74)
     11.1 Market Overview
     11.2 Market Ranking Analysis, 2017
     11.3 Competitive Situation and Trends
             11.3.1 Product Launches and Approvals
             11.3.2 Acquisitions
             11.3.3 Collaborations/Agreements/Partnerships
             11.3.4 Expansions

12 Company Profile (Page No. - 77)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Abbott Laboratories
     12.2 Danaher Corporation
     12.3 Biomιrieux Sa
     12.4 Roche Diagnostics
     12.5 Quidel
     12.6 Meridian Bioscience
     12.7 Mesa Biotech
     12.8 Genepoc
     12.9 DxNA
     12.10 Atlas Genetics
     12.11 Spartan Bioscience
     12.12 Biocartis

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 97)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports
     13.6 Author Details


List of Tables (68 Tables)

Table 1 Point-of-Care Molecular Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 2 Point-of-Care Molecular Diagnostics Market for Respiratory Diseases, By Region, 2016–2023 (USD Million)
Table 3 North America: Point-of-Care Molecular Diagnostics Market for Respiratory Diseases, By Country, 2016–2023 (USD Million)
Table 4 Point-of-Care Molecular Diagnostics Market for Sexually Transmitted Diseases, By Region, 2016–2023 (USD Million)
Table 5 North America: Point-of-Care Molecular Diagnostics Market for Sexually Transmitted Diseases, By Country, 2016–2023 (USD Million)
Table 6 Point-of-Care Molecular Diagnostics Market for Hospital-Associated Infections, By Region, 2016–2023 (USD Million)
Table 7 North America: Market for Hospital-Associated Infections, By Country, 2016–2023 (USD Million)
Table 8 Point-of-Care Molecular Diagnostics Market for Oncology, By Region, 2016–2023 (USD Million)
Table 9 North America: Market for Oncology, By Country, 2016–2023 (USD Million)
Table 10 Point-of-Care Molecular Diagnostics Market for Hepatitis, By Region, 2016–2023 (USD Million)
Table 11 North America: Market for Hepatitis, By Country, 2016–2023 (USD Million)
Table 12 Point-of-Care Molecular Diagnostics Market for Other Applications, By Region, 2016–2023 (USD Million)
Table 13 North America: Market for Other Applications, By Country, 2016–2023 (USD Million)
Table 14 Point-of-Care Molecular Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 15 Point-of-Care Molecular Diagnostics Market for RT -PCR, By Region, 2016–2023 (USD Million)
Table 16 North America: Market for RT -PCR, By Country, 2016–2023 (USD Million)
Table 17 Product Approvals in the Last Three Years
Table 18 Point-of-Care Molecular Diagnostics Market for INAAT, By Region, 2016–2023 (USD Million)
Table 19 North America: Market for INAAT, By Country, 2016–2023 (USD Million)
Table 20 Point-of-Care Molecular Diagnostics Market for Other Technologies, By Region, 2016–2023 (USD Million)
Table 21 North America: Market for Other Technologies, By Country, 2016–2023 (USD Million)
Table 22 Point-of-Care Molecular Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 23 POC Molecular Diagnostics Market for Assays & Kits, By Region, 2016–2023 (USD Million)
Table 24 North America: Market for Assays & Kits Market, By Country, 2016–2023 (USD Million)
Table 25 POC Molecular Diagnostics Market for Instruments, By Region, 2016–2023 (USD Million)
Table 26 North America: Market for Instruments, By Country, 2016–2023 (USD Million)
Table 27 POC Molecular Diagnostics Market for Software & Services, By Region, 2016–2023 (USD Million)
Table 28 North America: Market for Software & Services, By Country, 2016–2023 (USD Million)
Table 29 Point-of-Care Molecular Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 30 Point-of-Care Molecular Diagnostics Market for Physician Offices, By Region, 2016–2023 (USD Million)
Table 31 North America: Market for Physician Offices, By Country, 2016–2023 (USD Million)
Table 32 Point-of-Care Molecular Diagnostics Market for Hospital EDS & ICUS, By Region, 2016–2023 (USD Million)
Table 33 North America: Market for Hospital EDS & ICUS, By Country, 2016–2023 (USD Million)
Table 34 Point-of-Care Molecular Diagnostics Market for Research Institutes, By Region, 2016–2023 (USD Million)
Table 35 North America: Point-of-Care Molecular Diagnostics Market for Research Institutes, By Country, 2016–2023 (USD Million)
Table 36 Point-of-Care Molecular Diagnostics Market for Other End Users, By Region, 2016–2023 (USD Million)
Table 37 North America: Market for Other End Users, By Country, 2016–2023 (USD Million)
Table 38 Point-of-Care Molecular Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 39 North America: Market, By Country, 2016–2023 (USD Million)
Table 40 North America: Market, By Product & Service, 2016–2023 (USD Million)
Table 41 North America: Point-of-Care Molecular Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 42 North America: Point-of-Care Molecular Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 43 North America: Point-of-Care Molecular Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 44 US: Point-of-Care Molecular Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 45 US: Point-of-Care Molecular Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 46 US: Point-of-Care Molecular Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 47 US: Point-of-Care Molecular Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 48 Canada: Point-of-Care Molecular Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 49 Canada: Point-of-Care Molecular Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 50 Canada: Point-of-Care Molecular Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 51 Canada: Market, By Technology, 2016–2023 (USD Million)
Table 52 Europe: Market, By Product & Service, 2016–2023 (USD Million)
Table 53 Europe: Market, By Application, 2016–2023 (USD Million)
Table 54 Europe: Market, By End User, 2016–2023 (USD Million)
Table 55 Europe: Market, By Technology, 2016–2023 (USD Million)
Table 56 APAC: Market, By Product & Service, 2018–2023 (USD Million)
Table 57 APAC: Market, By Application, 2016–2023 (USD Million)
Table 58 APAC: stics Market, By End User, 2016–2023 (USD Million)
Table 59 APAC: Market, By Technology, 2016–2023 (USD Million)
Table 60 RoW: Market, By Product & Service, 2018–2023 (USD Million)
Table 61 RoW: Point-of-Care Molecular Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 62 RoW: Point-of-Care Molecular Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 63 RoW: Market, By Technology, 2016–2023 (USD Million)
Table 64 Rank of Companies in the Global Molecular POC Diagnostic Market, 2017
Table 65 Product Launches, 2015-2018
Table 66 Acquisitions, 2015-2018
Table 67 Collaborations/Partnerships/Agreements, 2015 & 2018
Table 68 Expansions, 2015 to 2018
 
 
List of Figures (23 Figures)
 
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation
Figure 6 POC Molecular Diagnostics Market, By Product & Service, 2018 vs 2023
Figure 7 POC Molecular Diagnostics Market, By Application, 2018 vs 2023
Figure 8 POC Molecular Diagnostics Market, By Technology, 2018 vs 2023
Figure 9 North America to Dominate the POC Molecular Diagnostics Market in 2018
Figure 10 Increasing Worldwide Prevalence of Infectious Diseases, A Key Driver for the Growth of the POC Molecular Diagnostics Market
Figure 11 Assays & Kits to Dominate the POC Molecular Diagnostics Market in Asia Pacific in 2017
Figure 12 Respiratory Diseases to Dominate the POC Molecular Diagnostics Market During the Forecast Period
Figure 13 Physician Offices to Dominate the POC Molecular Diagnostics Market During the Forecast Period
Figure 14 POC Molecular Diagnostic Market: Drivers, Restraints, & Opportunities
Figure 15 North America: Point-of-Care Molecular Diagnostics Market Snapshot
Figure 16 APAC: Point-of-Care Molecular Diagnostics Market Snapshot
Figure 17 Abbott Laboratories: Company Snapshot ( 2017)
Figure 18 Danaher Corporation: Company Snapshot (2017)
Figure 19 Biomιrieux Sa: Company Snapshot (2017)
Figure 20 Roche Diagnostics: Company Snapshot (2017)
Figure 21 Quidel: Company Snapshot (2016)
Figure 22 Meridian Bioscience: Company Snapshot (2017)
Figure 23 Biocartis: Company Snapshot (2017)

The global point of care (POC) molecular diagnostics market is projected to reach USD 1440.2 Million in 2023 from USD 725.5 Million in 2018, at CAGR of 14.7%. POC molecular diagnostics are point-of-care setting devices used by healthcare professionals to detect and diagnose various diseases in humans.

In this report, the POC molecular diagnostics market has been categorized by product & service, applications, technology, end user, and region.

The market is broadly segmented into instruments, assays & kits, and services & software based on the basis of products & services. The assays & kits segment is expected to account for the largest share of the global POC molecular diagnostics market. This segment is also projected to register the highest CAGR during the forecast period.

Based on the applications, the market is segmented into respiratory diseases, hospital-acquired infections (HAIs), sexually transmitted diseases (STDs), oncology, hepatitis, and other applications (meningococcal meningitis, malaria, Herpes Simplex Virus, Ebola, Zika virus). The respiratory diseases application segment is expected to account for the largest share of the global POC molecular diagnostics market in 2018. The large share of this segment can be attributed to the rising prevalence of influenza and TB, technological advancements in diagnostic tests, and the growing preference towards POC molecular diagnostics.

By technology, the POC molecular diagnostics market is segmented into RT-PCR, INAAT, and others technologies. In 2018, the RT-PCR segment is expected to account for the largest share of the global POC molecular diagnostics market. The large share of this segment can be attributed to the growing use of RT-PCR in proteomics and genomics and access to portable, easy-to-use devices.

In 2018, North America is expected to account for the largest share of the global POC molecular diagnostics market followed by Europe. The growing prevalence of infectious diseases, increasing number of CLIA product approvals, and rising government initiatives are the major factors driving the growth of this market in North America. However, Asia Pacific is expected to grow at highest CAGR during the forecast period. Growing initiatives by market players, rising demand for influenza A/B tests, and increasing patient population base in this region are the key factors driving this market.

Point of Care Molecular Diagnostics Market

Inadequate reimbursements and stringent and time-consuming regulatory policies that significantly increase the product launch cycle are factors expected to restrain the market growth to a certain extent.

The key players in the global POC molecular diagnostics market are Abbott Laboratories (US), Biomerieux (France), Danaher (US) Roche Diagnostics (Switzerland), Meridian Biosciences (US), Quidel (US). These players focus on organic and inorganic strategies such as product launches & approvals, expansions, acquisitions, partnerships, agreements, and collaborations to sustain their growth in the POC molecular diagnostics market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo